XTX Topco Ltd Takes $134,000 Position in Enhabit, Inc. (NYSE:EHAB)

XTX Topco Ltd purchased a new stake in shares of Enhabit, Inc. (NYSE:EHAB) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 15,199 shares of the company’s stock, valued at approximately $134,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of EHAB. Geode Capital Management LLC increased its position in shares of Enhabit by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 1,142,798 shares of the company’s stock valued at $8,927,000 after buying an additional 5,340 shares during the period. Wells Fargo & Company MN grew its holdings in shares of Enhabit by 24.8% during the fourth quarter. Wells Fargo & Company MN now owns 32,294 shares of the company’s stock worth $252,000 after purchasing an additional 6,415 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Enhabit by 1.3% during the fourth quarter. Invesco Ltd. now owns 286,676 shares of the company’s stock worth $2,239,000 after purchasing an additional 3,685 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Enhabit by 5.3% during the fourth quarter. Renaissance Technologies LLC now owns 208,700 shares of the company’s stock worth $1,630,000 after purchasing an additional 10,532 shares in the last quarter. Finally, Advisory Services Network LLC purchased a new position in shares of Enhabit during the fourth quarter worth about $125,000.

Wall Street Analysts Forecast Growth

Separately, UBS Group cut their price objective on Enhabit from $10.00 to $8.50 and set a “neutral” rating for the company in a report on Friday, August 8th.

Enhabit Stock Down 2.4%

Shares of NYSE EHAB opened at $7.39 on Friday. Enhabit, Inc. has a 12 month low of $6.47 and a 12 month high of $10.90. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $374.35 million, a price-to-earnings ratio of -2.77 and a beta of 1.68. The business has a 50-day moving average of $8.02 and a 200-day moving average of $8.52.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.10 by $0.03. Enhabit had a positive return on equity of 2.72% and a negative net margin of 12.84%. The company had revenue of $266.10 million during the quarter, compared to analyst estimates of $263.39 million. Sell-side analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Insider Transactions at Enhabit

In other news, CFO Ryan Solomon bought 10,000 shares of the business’s stock in a transaction on Friday, August 8th. The stock was acquired at an average price of $7.64 per share, with a total value of $76,400.00. Following the completion of the purchase, the chief financial officer directly owned 193,468 shares in the company, valued at $1,478,095.52. This represents a 5.45% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 3.40% of the stock is currently owned by corporate insiders.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.